GlassScriptPhysician profile
William S Bundrick
NPI 1326087354
$7,925.15
in general payments reported to CMS, 2019-2025
49 companies · $1,049 in 2025
The $1,049 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $492 · 2020: $648 · 2021: $1,273 · 2022: $1,555 · 2023: $1,359 · 2024: $1,550 · 2025: $1,049.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,957.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,957.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $812.34 | 2019-2025 | Lupron Depot, Botox |
| Astellas Pharma US INC | $643.13 | 2019-2025 | Xtandi |
| Pfizer INC. | $623.44 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $581.82 | 2021-2024 | Yonsa |
| Sumitomo Pharma America, INC. | $529.13 | 2023-2025 | Gemtesa |
| Endo Pharmaceuticals INC. | $435.41 | 2019-2024 | Xiaflex, Aveed |
| Teleflex LLC | $434.27 | 2021-2025 | Urolift |
| Antares Pharma, INC. | $387.58 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $350.11 | 2023-2025 | |
| Dendreon Pharmaceuticals LLC | $317.83 | 2024-2025 | Provenge |
| Myriad Genetic Laboratories, INC. | $292.87 | 2021-2023 | Prolaris |
| Procept Biorobotics Corporation | $279.31 | 2023-2025 | Aquabeam System, Aquabeam Robotic System |
| Urovant Sciences INC | $230.63 | 2021-2022 | |
| Allergan, INC. | $203.33 | 2019-2021 | |
| Endo USA, INC. | $194.06 | 2024-2025 | Xiaflex, Aveed |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Bundrick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.